tetano
Editor, Senior Moderator
Eur Heart J Case Rep
. 2021 Nov 19;5(12):ytab470.
doi: 10.1093/ehjcr/ytab470. eCollection 2021 Dec.
Multisystem inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection with delayed-onset myocarditis: case report
Miles Shen[SUP] 1 [/SUP], Aidan Milner[SUP] 1 [/SUP], Carlo Foppiano Palacios[SUP] 2 [/SUP], Tariq Ahmad[SUP] 3 [/SUP]
Affiliations
Abstract
Background: During the Coronavirus disease 2019 (COVID-19) pandemic, reports have emerged of a multisystem inflammatory syndrome in adults (MIS-A). Multisystem inflammatory syndrome in adults can affect various organ systems, including cardiovascular, gastrointestinal, and neurologic systems without significant respiratory involvement.
Case summary: A previously healthy 43-year-old man presented with fevers and abdominal pain then rapidly deteriorated into cardiogenic shock. His constellation of symptoms along with elevated inflammatory markers in the setting of a recent SARS-CoV-2 infection was consistent with the diagnosis of MIS-A. He also had a comprehensive infectious workup that was unremarkable, ruling out other potential infectious aetiologies for his presentation. He subsequently improved through supportive measures and after administration of intravenous immunoglobulin (IVIG). He later demonstrated recovery of cardiac function and cardiac magnetic resonance imaging (MRI) showed signs consistent with myocarditis.
Discussion: As the COVID-19 pandemic continues to be an ongoing issue, it is important to recognize MIS-A, a rare and potentially deadly clinical syndrome that can lead to profound cardiovascular complications. Non-invasive imaging modalities such as cardiac MRI can play a role in the identification of myocarditis. In addition to supportive management, adjunctive therapies such as IVIG may be efficacious in MIS-A and should be further investigated.
Keywords: 6.5 Cardiomyopathy; 2.3 Cardiac magnetic resonance; 6.2 Heart failure with reduced ejection fraction; 6.4 Acute heart failure; COVID-19; Case report; MIS-A; Multisystem inflammatory syndrome; Myocarditis; SARS-CoV-2.
. 2021 Nov 19;5(12):ytab470.
doi: 10.1093/ehjcr/ytab470. eCollection 2021 Dec.
Multisystem inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection with delayed-onset myocarditis: case report
Miles Shen[SUP] 1 [/SUP], Aidan Milner[SUP] 1 [/SUP], Carlo Foppiano Palacios[SUP] 2 [/SUP], Tariq Ahmad[SUP] 3 [/SUP]
Affiliations
- PMID: 35047731
- PMCID: PMC8759508
- DOI: 10.1093/ehjcr/ytab470
Abstract
Background: During the Coronavirus disease 2019 (COVID-19) pandemic, reports have emerged of a multisystem inflammatory syndrome in adults (MIS-A). Multisystem inflammatory syndrome in adults can affect various organ systems, including cardiovascular, gastrointestinal, and neurologic systems without significant respiratory involvement.
Case summary: A previously healthy 43-year-old man presented with fevers and abdominal pain then rapidly deteriorated into cardiogenic shock. His constellation of symptoms along with elevated inflammatory markers in the setting of a recent SARS-CoV-2 infection was consistent with the diagnosis of MIS-A. He also had a comprehensive infectious workup that was unremarkable, ruling out other potential infectious aetiologies for his presentation. He subsequently improved through supportive measures and after administration of intravenous immunoglobulin (IVIG). He later demonstrated recovery of cardiac function and cardiac magnetic resonance imaging (MRI) showed signs consistent with myocarditis.
Discussion: As the COVID-19 pandemic continues to be an ongoing issue, it is important to recognize MIS-A, a rare and potentially deadly clinical syndrome that can lead to profound cardiovascular complications. Non-invasive imaging modalities such as cardiac MRI can play a role in the identification of myocarditis. In addition to supportive management, adjunctive therapies such as IVIG may be efficacious in MIS-A and should be further investigated.
Keywords: 6.5 Cardiomyopathy; 2.3 Cardiac magnetic resonance; 6.2 Heart failure with reduced ejection fraction; 6.4 Acute heart failure; COVID-19; Case report; MIS-A; Multisystem inflammatory syndrome; Myocarditis; SARS-CoV-2.